FDA Advisers recommend Agency Approve 4th COVID vaccine
Option Novavax: FDA’s Dr. Peter Marks said the new vaccine may encourage those who have not taken the COVID shot to consider doing so.
By
A Food and Drug Administration advisory panel voted Tuesday to recommend that the agency authorize Novavax as a fourth COVID-19 vaccine option for adults.
Novavax, a traditional protein vaccine, is already in use in Australia, Canada, parts of Europe and elsewhere, according to the Associated Press.
FDA vaccine head Dr. Peter Marks said the new vaccine may encourage those who have not taken the COVID shot to consider doing so.
“We do have a problem with vaccine uptake that is very serious in the United States,” he said. “Anything we can do to get people more comfortable to accept these potentially life-saving products is something that we feel we are compelled to do.”
The panel voted 21-0 with one abstention to recommend that the FDA approve the Novavax shot.
Novavax is different from other COVID vaccines such as Pfizer and Moderna that provide genetic instructions to the body while the Johnson and Johnson vaccine uses a cold virus.
RELATED
D.C. health officials report potential monkeypox case in the nation’s capital
You Vote: Should the U.S. join a global pandemic treaty?
GOP lawmakers push legislation to preempt WHO global pandemic treaty
***********
(TLB) published this article with permission of John Solomon at Just the News. Click Here to read about the staff at Just the News
Emphasis added by (TLB) editors
Header featured image (edited) credit: Needle/product bottle/Getty Image
••••
••••
Stay tuned to …
••••
The Liberty Beacon Project is now expanding at a near exponential rate, and for this we are grateful and excited! But we must also be practical. For 7 years we have not asked for any donations, and have built this project with our own funds as we grew. We are now experiencing ever increasing growing pains due to the large number of websites and projects we represent. So we have just installed donation buttons on our websites and ask that you consider this when you visit them. Nothing is too small. We thank you for all your support and your considerations … (TLB)
••••
Comment Policy: As a privately owned web site, we reserve the right to remove comments that contain spam, advertising, vulgarity, threats of violence, racism, or personal/abusive attacks on other users. This also applies to trolling, the use of more than one alias, or just intentional mischief. Enforcement of this policy is at the discretion of this websites administrators. Repeat offenders may be blocked or permanently banned without prior warning.
••••
Disclaimer: TLB websites contain copyrighted material the use of which has not always been specifically authorized by the copyright owner. We are making such material available to our readers under the provisions of “fair use” in an effort to advance a better understanding of political, health, economic and social issues. The material on this site is distributed without profit to those who have expressed a prior interest in receiving it for research and educational purposes. If you wish to use copyrighted material for purposes other than “fair use” you must request permission from the copyright owner.
••••
Disclaimer: The information and opinions shared are for informational purposes only including, but not limited to, text, graphics, images and other material are not intended as medical advice or instruction. Nothing mentioned is intended to be a substitute for professional medical advice, diagnosis or treatment.
Leave a Reply